GDRX GoodRx Holdings, Inc.

$3.39▲ +1.19% Healthcare Other
After hours $3.39▲ +0.00% Sep 11, 7:30 PM ET
Volume 491.8K Avg Volume (10D) 1.17M
Key Metrics & Fundamentals
Market Cap
$1.16B
P/E Ratio
56.5
Div Yield
–%
52W Range
1.77 - 5.81
% vs 50 MA
2.03%
% vs 200 MA
25.24%
RSI-14
47.6
MACD Histogram
-0.0400
Beta (1Y vs SPY)
1.40
Free Cash Flow
$66.42M
Gross Rev
$200.41M
Gross Profit
$179.41M
EBITDA
$47.55M
COGS
$21.00M
Operating Exp
$155.78M
Operating Income
$23.63M
EBIT
$23.63M
Pretax Income
$15.47M
Net Income
$8.54M
EPS (Diluted)
0.02
Price & Volume History
Loading chart…
Recent News
From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household
Business Wire · Sep 3, 2026 1:00 PM
1 Momentum Stock with Exciting Potential and 2 That Underwhelm
StockStory · Sep 1, 2026 10:18 AM
Reflecting On Healthcare Technology Stocks’ Q2 Earnings: GoodRx (NASDAQ:GDRX)
StockStory · Aug 14, 2026 3:49 PM
1 Small-Cap Stock with Solid Fundamentals and 2 Facing Headwinds
StockStory · Aug 13, 2026 2:21 PM
GoodRx (GDRX) Stock Looks Overvalued On Its Earnings Outlook
Simply Wall St. · Aug 13, 2026 8:09 AM
GoodRx Holdings (GDRX) Could Be 13% Overvalued After Q2 Earnings and Guidance Raise
Simply Wall St. · Aug 13, 2026 7:51 AM
GoodRx (GDRX) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 12, 2026 11:03 PM
GDRX Q2 Deep Dive: Pharma Direct and Subscription Growth Drive Upgraded Outlook
StockStory · Aug 11, 2026 3:09 PM
1 Stock Under $10 with Exciting Potential and 2 Facing Headwinds
StockStory · Aug 10, 2026 8:05 PM
Morgan Stanley Adjusts Price Target on GoodRx to $4 From $3, Maintains Equalweight Rating
MT Newswires · Aug 7, 2026 9:28 AM
Financial Overview - Income Statement Quarterly

See GDRX's money flow as a full page

Social Sentiment
Avg +0.64 · 6 posts
GoodRx, a turn around opportunity. ($GDRX)
r/stocks · Mar 1, 2026
The post highlights positive aspects like low prices, consumer love, profitability, and experienced leadership, suggesting a potential investment opportunity. However, the commenter also acknowledges a 10% loss.
positive +0.20
NewsDiscussionTradeDDTrumpRx is a front for GDRX but nobody cares about the stock
r/wallstreetbets · Feb 6, 2026
The post highlights revenue growth, strong free cash flow margins, and favorable valuation metrics for GDRX, leading to a bullish sentiment.
positive +0.60
NewsDiscussionPriceTargetDoes anyone think GDRX is a good buy?
r/investing · Aug 20, 2025
The post highlights a potential catalyst (Novo Nordisk partnership) and discusses significant undervaluation, driving a bullish sentiment.
positive +0.80
NewsTradePriceTargetGoodRx jumps 34% after deal to sell Novo Nordisk’s GLP-1 drugs at $499/month as demand for weight-loss meds surges
r/wallstreetbets · Aug 18, 2025
Strong positive sentiment due to the significant stock increase and a key partnership.
very_positive +1.00
NewsEarningsDiscussionPriceTargetHow do you feel about GDRX?
r/wallstreetbets · Aug 10, 2025
The author believes it's a good time to buy due to the low price and potential for growth, despite recent earnings.
positive +0.60
Page 1 of 2 (6 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙